How will melanoma detection change over the next decade? This is the question posed in this episode from Melanoma Institute Australia’s podcast Melanoma Insights for Professionals. It is also a key question that underpins our work leading the development of the Roadmap for a National Targeted Melanoma Screening Program.
In the podcast, four multidisciplinary experts explore how targeted screening, personalised risk assessment, advanced imaging, artificial intelligence and evolving models of care could transform the way melanoma is detected. The discussion provides insight into how we ca can identify those most likely to benefit from screening, reduce unnecessary biopsies and surveillance, and make best use of Australia’s limited healthcare workforce and resources.
The podcast provides an excellent overview of work underway in the Roadmap for a National Targeted Melanoma Screening Program and the crucial considerations being deliberated to provide the Australian government with a potential design for a safe, effective, and equitable screening program.
The podcast features four members of the Roadmap team: Professor Pascale Guitera (Melanoma Institute Australia) and Professor Tori Mar (Victorian Melanoma Service), both dermatologists who are members of Roadmap Workstream 2 (Screening Intervention & Management); Dr Amelia Smit (Daffodil Centre, The University of Sydney), an expert in risk communication and qualitative research in the Roadmap Operations Team; and Professor Rachael Morton (The University of Sydney), health economist, who is a member of Roadmap Workstream 3 (Data Collection, Linkage and Registry).
You can find the podcast on Spotify here or search for ‘Melanoma Insights’ on your favourite podcast app.
Leggi l'articolo originale su Melanoma Institute Australia